Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - NET INCOME
Net Income ESPR - Esperion Therapeutics, Inc.
-209 M
LAST VALUE
11.82%
2 YEAR CAGR
-0.73%
5 YEAR CAGR
-23.15%
10 YEAR CAGR